AbbVie has never been shy about guarding its patents and hiking drug prices. Congress tore into the company this week. But will it lead to any real policy change? Read More
Related Articles
Running is the best Way for staying Active while WFH
Working at home is tough. Running assists –a whole good deal. It will help me. I do not presume to inform anybody, but I am prepared to tell my story if requested. (And I had been requested by my editor) As a dedicated runner for several decades, I am finding it more precious than ever […]
U.S. says it is ready for cyber election dangers. But flaws remain
Founded by Russia’s concerted attempt to gallop in the previous election, state and federal officials have determined what they think are powerful obstacles to thwart cyber-attacks before Tuesday’s presidential vote. Cybersecurity specialists, including those licensed to deploy army cyber abilities, have been brought together to make an’all of authorities’ attempt to ensure Republicans determine whether […]
Inside Sephora’s plan to win back shoppers
Sephora is laying out a plan to rehab its image with shoppers of color who’d alleged racial bias in stores and a lack of products that cater to their needs. The plan, unveiled on Wednesday, includes cracking down on discrimination among its staff, doubling its assortment of Black-owned brands by the end of the year and scaling back third-party security […]